Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Must-know: Why Pfizer could up its offer for AstraZeneca
Yahoo/Market Realist
Friday, May 16, 2014 - 9:13am
tags:
Pfizer, M&A, AstraZeneca
The GSK Crackdown Takes A Very Personal Turn
Forbes
Friday, May 16, 2014 - 9:11am
tags:
GSK, China
Abbott to buy Latin American drugmaker CFR in $2.9 billion deal
Yahoo/Reuters
Friday, May 16, 2014 - 9:09am
tags:
M&A, Abbott Labs, CFR
Takeda not interested in synergy or tax-driven M&A - CFO
Yahoo/Reuters
Friday, May 16, 2014 - 8:22am
tags:
M&A, Takeda
Think Like A Brain Surgeon: Dr. Christopher James Offers Fresh Perspectives On 6 Exciting Biotechs
Seeking Alpha
Friday, May 16, 2014 - 8:20am
tags:
Amgen, Biocryst, GSK, Corcept Therapeutics, Merck KGaA, Ligand Pharmaceuticals, MannKind, Pfizer, Shire, Receptos, Opexa
Novartis Fails to Win U.S. Approval for Serelaxin Heart Drug
Bloomberg
Friday, May 16, 2014 - 7:54am
tags:
Novartis, serelaxin, heart failure
Searching Social Media for Drug Side Effects
Bloomberg/Businessweek
Friday, May 16, 2014 - 7:51am
tags:
side effects, Treato, social media
Exclusive: Pfizer chiefs sold £15m of their own shares weeks before bid
Independent, UK
Friday, May 16, 2014 - 7:48am
tags:
Pfizer, M&A, AstraZeneca
Novartis reports issuance of CRL for RLX030 by FDA
The Fly on the Wall
Friday, May 16, 2014 - 7:47am
tags:
Novartis, RLX030, FDA, acute heart failure
FDA lowers starting dose of sleep drug Lunesta over safety
Yahoo/Reuters
Thursday, May 15, 2014 - 6:20pm
tags:
FDA, insomnia, Lunesta, Sunovion
A Look at Pfizer’s Recent Financial Performance
Wall St Cheat Sheet
Thursday, May 15, 2014 - 6:11pm
tags:
Pfizer
Clovis shares jump as company prepares to give cancer drug results
Marketwatch
Thursday, May 15, 2014 - 6:08pm
tags:
Clovis Oncology, CO-1686
Mergers seem to be a prescription for growth for pharmaceuticals
Yahoo/Market Realist
Thursday, May 15, 2014 - 5:59pm
tags:
M&A, Pfizer, GSK, Merck, Bayer, AstraZeneca, Valeant Pharmaceuticals, Novartis, Eli Lilly
Could Bristol-Myers End Up Acquiring Celldex?
Motley Fool
Thursday, May 15, 2014 - 5:55pm
tags:
Celldex, M&A, Bristol-Myers Squibb
CDC backing for preventive Truvada could multiply Gilead's scripts 50-fold
Fierce Pharma
Thursday, May 15, 2014 - 11:11am
tags:
CDC, Truvada, HIV, Gilead Sciences
Reckitt Benckiser to develop XenoPort alcohol abuse drug
Yahoo/Reuters
Thursday, May 15, 2014 - 11:08am
tags:
alcoholism, Reckitt Benckiser, XenoPort, Suboxone
Merck KGaA Beats on Q1 Earnings
Yahoo/Zacks.com
Thursday, May 15, 2014 - 11:05am
tags:
earnings, Merck KGaA
Northwest Biotherapeutics Reports On Sarcoma Patient Treated With DCVAx-Direct
Seeking Alpha
Thursday, May 15, 2014 - 11:04am
tags:
Northwest Biotherapeutics, sarcoma, DCVax Direct
Why This Little-Known Biotech Is An Enticing Takeover And New-Products Play
Forbes
Thursday, May 15, 2014 - 11:02am
tags:
Spectrum Pharmaceuticals
Kindred Healthcare Offers to Acquire Gentiva Health
Bloomberg
Thursday, May 15, 2014 - 11:01am
tags:
Kindred Healthcare, home healthcare, Gentiva Health Services, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.